RecruitingNCT07683247

Intraoperative Energy Expenditure During ACL Reconstruction Surgery

Prospective Assessment of Surgeon Energy Expenditure Using Hexoskin During Anterior Cruciate Ligament Reconstruction: Influence of Anterolateral Ligament Reconstruction and Meniscal Procedures


Sponsor

ASL Lecce

Enrollment

80 participants

Start Date

Feb 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This prospective observational study evaluates the intraoperative energy expenditure of the surgeon during anterior cruciate ligament reconstruction procedures. Energy expenditure and physiological workload will be measured using a wearable Hexoskin shirt during surgery. The study will compare surgical procedures involving isolated anterior cruciate ligament reconstruction, anterior cruciate ligament reconstruction combined with anterolateral ligament reconstruction, and procedures requiring additional meniscal treatment. The aim is to determine whether anterolateral ligament reconstruction meaningfully increases surgeon workload and whether meniscal procedures are associated with higher intraoperative energy expenditure.


Eligibility

Min Age: 16 YearsMax Age: 49 Years

Inclusion Criteria4

  • Patients undergoing primary anterior cruciate ligament reconstruction
  • Unilateral ACL rupture confirmed by clinical examination and MRI
  • Surgery performed by the participating surgeon wearing the Hexoskin device
  • Ability to provide written informed consent

Exclusion Criteria6

  • Revision ACL reconstruction
  • Multiligament knee reconstruction
  • Bilateral knee surgery
  • Concomitant procedures other than ACL reconstruction, ALL reconstruction, meniscal repair, or partial meniscectomy
  • Incomplete intraoperative Hexoskin recording
  • Conversion or interruption of the planned surgical procedure

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Vito Fazzi Hospital

Lecce, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07683247


Related Trials